Cargando…

GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma

BACKGROUND: Cancer stem cells (CSCs) are implicated in carcinogenesis, cancer progression, and recurrence. Several biomarkers have been described for pancreatic ductal adenocarcinoma (PDAC) CSCs; however, their function and mechanism remain unclear. METHOD: In this study, secretome analysis was perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Jung Hyun, Kim, Sun A, Lee, Jeong Hoon, Park, Yu Rang, Kim, Chanyang, Park, Soo Been, Jung, Dawoon E., Lee, Hee Seung, Chung, Moon Jae, Song, Si Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603516/ https://www.ncbi.nlm.nih.gov/pubmed/34794402 http://dx.doi.org/10.1186/s12885-021-08898-y

Ejemplares similares

Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm
por: Lee, Jaehoon, et al.
Publicado: (2021)

Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
por: Kim, Kwondo, et al.
Publicado: (2019)

Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome
por: Jo, Jung Hyun, et al.
Publicado: (2019)

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
por: Jo, Jung Hyun, et al.
Publicado: (2022)

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
por: Jung, Dawoon E., et al.
Publicado: (2017)

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
por: Park, Ji Hoon, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
por: Lee, Hee Seung, et al.
Publicado: (2023)

Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
por: Lee, Hee Seung, et al.
Publicado: (2023)

Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
por: Lee, Hee Seung, et al.
Publicado: (2018)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease
por: Choi, Yeon Joo, et al.
Publicado: (2021)

Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma
por: Choi, Munseok, et al.
Publicado: (2021)

Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma
por: Koh, Youngil, et al.
Publicado: (2023)

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
por: Chang, Yuanhao, et al.
Publicado: (2020)

Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?
por: Kang, Chang Moo, et al.
Publicado: (2020)

Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
por: Ryu, Kum Hei, et al.
Publicado: (2023)

Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells
por: Cho, Jae Hee, et al.
Publicado: (2017)

Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy
por: Goong, Hyeon Jeong, et al.
Publicado: (2015)

Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma
por: Jang, Sung-Ill, et al.
Publicado: (2022)

Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma
por: Kim, Hyemin, et al.
Publicado: (2021)

The Relationship of Anatomic Variation of Pancreatic Ductal System and Pancreaticobiliary Diseases
por: Bang, Seungmin, et al.
Publicado: (2006)

The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
por: Park, Joo Kyung, et al.
Publicado: (2016)

Mitochondrial Glrx2 Knockout Augments Acetaminophen-Induced Hepatotoxicity in Mice
por: Li, Jing, et al.
Publicado: (2022)

Clinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma
por: CHOI, SUNG HOON, et al.
Publicado: (2013)

ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma
por: Lee, Jae-Seon, et al.
Publicado: (2020)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
por: Pyo, Jung-Soo, et al.
Publicado: (2021)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Usefulness of Inflammation-Based Prognostic Scores in Patients with Surgically Treated Pancreatic Ductal Adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
por: Lee, Jee-Soo, et al.
Publicado: (2019)

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
por: Shin, Sang Hyun, et al.
Publicado: (2017)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed Tomography
por: Ko, Sung Woo, et al.
Publicado: (2022)

Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location
por: Sung, Min Kyu, et al.
Publicado: (2021)

Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse
por: Lee, Jae-Seon, et al.
Publicado: (2021)

PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells
por: Shin, Min Jea, et al.
Publicado: (2020)

Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma
por: Goh, Tae Sik, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o87diqh1hc2ogil30vkkhh4nfl